Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: Mechanism of action and relevance to psychiatric disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 5, 2008, Pages 1118-1130

  Pérez Neri, Iván ^a   Montes, Sergio ^a   Ojeda López, Carmen ^a   Ramírez Bermúdez, Jesús ^a   Ríos, Camilo ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Anxiety; Cerebral blood flow; Major depressive disorder; Mood; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; NITRIC OXIDE; PRASTERONE; PRASTERONE SULFATE;

ANXIETY; BRAIN BLOOD FLOW; CHANNEL GATING; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; HUMAN; MAJOR DEPRESSION; NEUROENDOCRINOLOGY; NEUROMODULATION; NEUROPATHOLOGY; REVIEW; SCHIZOPHRENIA; STEROID METABOLISM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; HUMANS; MENTAL DISORDERS; MODELS, BIOLOGICAL; NEUROTRANSMITTER AGENTS;

EID: 47949106157     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.12.001     Document Type: Review

References (142)

1. Arlt W., Callies F., van Vlijmen J.C., Koehler I., Reincke M., Bidlingmaier M., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341 (1999) 1013-1020
2. Arlt W., Callies F., Koehler I., van Vlijmen J.C., Fassnacht M., and Strasburger C.J. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. J Clin Endocrinol Metab 86 (2001) 4686-4692
3. Assies J., Visser I., Nicolson N.A., Eggelte T.A., Wekking E.M., Huyser J., et al. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings. Psychiatry Res 128 (2004) 117-122
4. Bachneff S.A. Regional cerebral blood flow in schizophrenia and the local circuit neurons hypothesis. Schizophr Bull 22 (1996) 163-182
5. Barbagallo M., Shan J., Pang P.K.T., and Resnick L.M. Effects of dehydroepiandrosterone sulfate on cellular calcium responsiveness and vascular contractility. Hypertension 26 (1995) 1065-1069
6. Barbosa A.D.E., and Morato G.S. Influence of neurosteroids on the development of rapid tolerance to ethanol in mice. Eur J Pharmacol 431 (2001) 179-188
7. Bergeron R., de Montigny C., and Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 76 (1996) 1193-1202
8. Bloch M., Schmidt P.J., Danaceau M.A., Adams L.F., and Rubinow D.R. Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry 45 (1999) 1533-1541
9. Bonnet S., Dumas-de-La-Roque E., Bégueret H., Marthan R., Fayon M., Dos Santos P., et al. Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension. Proc Natl Acad Sci U S A 100 (2003) 9488-9493
10. Brambilla F., Biggio G., Pisu M.G., Bellodi L., Perna G., Bogdanovich-Djukic V., et al. Neurosteroid secretion in panic disorder. Psychiatry Res 118 (2003) 107-116
11. Brambilla F., Mellado C., Alciati A., Pisu M.G., Purdy R.H., Zanone S., et al. Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder. Psychiatry Res 135 (2005) 185-190
12. 2+levels in a pituitary cell line. Eur J Pharmacol 298 (1996) 79-85
13. A receptor. J Endocrinol 158 (1998) 121-125
14. Carlson L.E., and Sherwin B.B. Relationships among cortisol (CRT), dehydroepiandrosterone-sulfate (DHEAS), and memory in a longitudinal study of healthy elderly men and women. Neurobiol Aging 20 (1999) 315-324
15. Carlson L.E., Sherwin B.B., and Chertkow H.M. Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls. Horm Behav 35 (1999) 254-263
16. Catalina F., Speciale S.G., Kumar V., Milewich L., and Bennett M. Food restriction-like effects of dietary dehydroepiandrosterone. Hypothalamic neurotransmitters and metabolites in male C57BL/6 and (C57BL/6 × DBA/2)F1 mice. Exp Biol Med 226 (2001) 208-215
17. Catalina F., Milewich L., Frawley W., Kumar V., and Bennett M. Decrease of core body temperature in mice by dehydroepiandrosterone. Exp Biol Med 227 (2002) 382-388
18. Centonze D., Gubellini P., Bernardi G., and Calabresi P. Permissive role of interneurons in corticostriatal synaptic plasticity. Brain Res Rev 31 (1999) 1-5
19. Charalampopoulos I., Dermitzaki E., Vardouli L., Tsatsanis C., Stournaras C., Margioris N., et al. Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 146 (2005) 3309-3318
20. Chen L., Dai X.N., and Sokabe M. Chronic administration of dehydroepiandrosterone sulfate (DHEAS) primes for facilitated induction of long-term potentiation via sigma 1 (σ1) receptor: optical imaging study in rat hippocampal slices. Neuropharmacology 50 (2006) 380-392
21. Chen L., Miyamoto Y., Furuya K., Dai X.N., Mori N., and Sokabe M. Chronic DHEAS administration facilitates hippocampal long-term potentiation via an amplification of Src-dependent NMDA receptor signaling. Neuropharmacology 51 (2006) 659-670
22. Compagnone N.A., and Mellon S.H. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci U S A 95 (1998) 4678-4683
23. Compagnone N.A., and Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 21 (2000) 1-56
24. Compagnone N.A., Bulfone A., Rubenstein J.L.R., and Mellon S.H. Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology 136 (1995) 5212-5223
25. Compagnone N.A., Bulfone A., Rubenstein J.L.R., and Mellon S.H. Expression of the steroidogenic enzyme P45Oscc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology 138 (1995) 2669-2696
26. Correa F., García N., García G., and Chávez E. Dehydroepiandrosterone as an inducer of mitochondrial permeability transition. J Steroid Biochem Mol Biol 87 (2003) 279-284
27. Cosi C., Carilla-Durand E., Assié M.B., Ormiere A.M., Maraval M., Leduc N., et al. Partial agonist properties of the antipsychotics SR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. Eur J Pharmacol 535 (2006) 135-144
28. Dean C.E. Prasterone (DHEA) and mania. Ann Pharmacother 34 (2000) 1419-1422
29. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Moreno F.A., et al. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 46 (1999) 212-220
30. A receptor. Neuroscience 45 (1991) 127-135
31. 2-Receptor regulation of dopamine transporter via activation of protein kinase C. J Pharmacol Exp Ther 301 (2002) 306-314
32. di Michele F., Caltagirone C., Bonaviri G., Romeo E., and Spalletta G. Plasma dehydroepiandrosterone levels are strongly increased in schizophrenia. J Psychiatr Res 39 (2005) 267-273
33. Dong L.Y., Cheng Z.X., Fu Y.M., Wang Z.M., Zhu Y.H., Sun J.L., et al. Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and sigma-1 receptor. Neuropharmacology 52 (2007) 966-974
34. Do-Rego J.L., Mensah-Nyagan G.A., Beaujean D., Vaudry D., Sieghart W., Luu-The V., et al. γ-Aminobutyric acid, acting through γ-aminobutyric acid type A receptors, inhibits the biosynthesis of neurosteroids in the frog hypothalamus. Proc Natl Acad Sci U S A 97 (2000) 13925-13930
35. Drevets W.C., Gautier C., Price J.C., Kupfer D.J., Kinahan P.E., Grace A.A., et al. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49 (2001) 81-96
36. A receptor-mediated chloride uptake. Brain Res 790 (1998) 334-338
37. Elhwuegi A.S. Central monoamines and their role in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 28 (2004) 435-451
38. Fedotova J., and Sapronov N. Behavioral effects of dehydroepiandrosterone in adult male rats. Prog Neuro-Psychopharmacol Biol Psychiatry 28 (2004) 1023-1027
39. 2+ channel current in freshly isolated hippocampal CA1 neurons. Eur J Pharmacol 202 (1991) 1269-1272
40. Flood J.F., Morley J.E., and Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci U S A 89 (1992) 1567-1571
41. Frye C.A., and Lacey E.H. The neurosteroids DHEA and DHEAS may influence cognitive performance by altering affective state. Physiol Behav 66 (1999) 85-92
42. García-Arenas G., Ramírez-Amaya V., Balderas I., Sandoval J., Escobar M.L., Ríos C., et al. Cognitive deficits in adult rats by lead intoxication are related with regional specific inhibition of cNOS. Behav Brain Res 149 (2004) 49-59
43. Garcia de Yebenes E., Hong M., and Pelletier G. Effects of dehydroepiandrosterone (DHEA) on pituitary prolactin and arcuate nucleus neuron tyrosine hydroxylase mRNA levels in the rat. J Neuroendocrinol 7 (1995) 589-595
44. Gillen G., Porter J.R., and Svec F. Synergistic anorectic effect of dehydroepiandrosterone and d-fenfluramine on the obese Zucker rat. Physiol Behav 67 (1999) 173-179
45. 3H]dopamine release from rat stirtal slices by sigma receptor ligands. J Pharmacol Exp Ther 271 (1994) 212-219
46. Gordon C.M., Grace E., Emans S.J., Feldman H.A., Goodman E., Becker K.A., et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 87 (2002) 4935-4941
47. Guazzo E.P., Kirkpatrick P.J., Goodyer I.M., Shiers H.M., and Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 81 (1996) 3951-3960
48. Gupte S.A., Li K.X., Okada T., Sato K., and Oka M. Inhibitors of pentose phosphate pathway cause vasodilation: involvement of voltage-gated potassium channels. J Pharmacol Exp Ther 301 (2002) 299-305
49. Gupte S.A., Tateyama M., Okada T., Oka M., and Ochi R. Epiandrosterone, a metabolite of testosterone precursor, blocks L-type calcium channels of ventricular myocytes and inhibits myocardial contractility. J Mol Cell Cardiol 34 (2002) 679-688
50. Hansen S.L., Fjalland B., and Jackson M.B. Differential blockade of γ-aminobutyric acid type A receptors by the neuroactive steroid dehydroepiandrosterone sulfate in posterior and intermediate pituitary. Mol Pharmacol 55 (1999) 489-496
51. Hargrave K.R., Wright B.E., Svec F., and Porter J.R. Dietary and hypothalamic changes in Δ4-androstenedione-treated zucker rats. Physiol Behav 61 (1997) 619-626
52. Harris D.S., Wolkowitz O.M., and Reus V.I. Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients. World J Biol Psychiatry 2 (2001) 99-102
53. Haug M., Ouss-Schlegel M.L., Spetz J.F., Brain P.F., Simon T.V., Baulieu E.E., et al. Suppressive effects of dehydroepiandrosterone and 3-β-Methylandrost-5-en-17-one on attack towards lactating female intruders by castrated male mice. Physiol Behav 46 (1989) 955-959
54. Hayashi T., Esaki T., Muto E., Kano H., Asai Y., Thakur N.K., et al. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide. Arterioscler Thromb Vasc Biol 20 (2000) 782-792
55. Heuser I., Deuschle M., Luppa P., Schweiger U., Standhardt H., and Weber B. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 83 (1998) 3130-3133
56. Hillen T., Lun A., Reischies F.M., Borchelt M., Steinhagen-Thiessen E., and Schaub R.T. DHEA-S plasma levels and incidence of Alzheimer's disease. Biol Psychiatry 47 (2000) 161-163
57. Hojo Y., Hattori T., Enami T., Furukawa A., Suzuki K., Ishii H., et al. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017α and P450 aromatase localized in neurons. Proc Natl Acad Sci U S A 101 (2004) 865-870
58. Honey G.D., and Fletcher P.D. Investigating principles of human brain function underlying working memory: what insights from schizophrenia?. Neuroscience 139 (2006) 59-71
59. A receptors in neonatal hypothalamic brain slice. J Neurophysiol 88 (2002) 1655-1663
60. Hunt P.J., Gurnell E.M., Huppert F.A., Richards C., Prevost A.T., Wass J.A.H., et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85 (2000) 4650-4656
61. Imamura M., and Prasad C. Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem Biophys Res Commun 243 (1998) 771-775
62. Izumi T., Inoue T., Kitaichi Y., Nakagawa S., and Koyama T. Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor. Eur J Pharmacol 534 (2006) 129-132
63. Kaasik A., Safiulina D., Kalda A., and Zharkovsky A. Dehydroepiandrosterone with other neurosteroids preserve neuronal mitochondria from calcium overload. J Steroid Biochem Mol Biol 87 (2003) 97-103
64. Katz J.L., Libby T.A., Kopajtic T., Husbands S.H., and Newman A.H. Behavioral effects of rimcazole analogues alone and in combination with cocaine. Eur J Pharmacol 468 (2003) 109-119
65. King S.R., Manna P.R., Ishii T., Syapin P.J., Ginsberg S.D., Wilson K., et al. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J Neurosci 22 (2002) 10613-10620
66. Kline M.D., and Jaggers E.D. Mania onset while using dehydroepiandrosterone. Am J Psychiatry 156 (1999) 970
67. 2+ channels in rat hippocampal neurons: a comparison with dehydroepiandrosterone. Eur J Pharmacol 416 (2001) 203-212
68. Kurata K., Takebayashi M., Morinobu S., and Yamawaki S. β-Estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-D-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms. J Pharmacol Exp Ther 311 (2004) 237-245
69. A receptors. Stroke 31 (2000) 1953-1957
70. A receptor modulating neuroactive steroids in patients with social phobia. Psychiatry Res 137 (2005) 131-136
71. Lavi S., Egbarya R., Lavi R., and Jacob G. Role of nitric oxide in the regulation of cerebral blood flow in humans: chemoregulation versus mechanoregulation. Circulation 107 (2003) 1901-1905
72. A receptor in pituitary melanotrope cells. Eur J Pharmacol 331 (1997) 303-311
73. Lhullier F.L.R., Nicolaidis R., Riera N.G., Cipriani F., Junqueira D., Dahm K.C.S., et al. Dehydroepiandrosterone increases synaptosomal glutamate release and improves the performance in inhibitory avoidance task. Pharmacol Biochem Behav 77 (2004) 601-606
74. Liu D., and Dillon J.S. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Gαi2,3. J Biol Chem 277 (2002) 21379-21388
75. Liu D., and Dillon J.S. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 69 (2004) 279-289
76. Liu P.S., Lin M.K., and Hsieh H.L. Dehydroepiandrosterone sulfate inhibition of catecholamine secretion from bovine adrenal chromaffin cells. Neurosci Lett 204 (1996) 181-184
77. Maayan R., Touati-Werner D., Ram E., Strous R., Keren O., and Weizman A. The protective effect of frontal cortex dehydroepiandrosterone in anxiety and depressive models in mice. Pharmacol Biochem Behav 85 (2006) 415-421
78. A receptor. Brain Res 526 (1990) 143-146
79. A receptor-ionophores. Neuropharmacology 44 (2003) 994-1002
80. Manabe A., Hata T., Yanagihara T., Hashimoto M., Tamada Y., Irikoma S., et al. Nitric oxide synthesis is increased after dehydroepiandrosterones sulphate administration in term human pregnancy. Hum Reprod 14 (1999) 2116-2119
81. Markowitz J.S., Carson W.H., and Jackson C.W. Possible dihydroepiandrosterone-induced mania. Biol Psychiatry 45 (1999) 241-242
82. Marx C.E., Stevens R.D., Shampine L.J., Uzunova V., Trost W.T., Butterfield M.I., et al. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. Neuropsychopharmacology 31 (2006) 1249-1263
83. 1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res Rev 37 (2001) 116-132
84. McCracken K.A., Bowen W.D., and Matsumoto R.R. Novel σ receptor ligands attenuate the locomotor stimulatory effects of cocaine. Eur J Pharmacol 365 (1999) 35-38
85. McCracken K.A., Bowen W.D., de Costa B.R., and Matsumoto R.R. Two novel σ receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity. Eur J Pharmacol 370 (1999) 225-232
86. Melchior C.L., and Ritzmann R.F. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav 47 (1994) 437-441
87. Mellon S.H., Griffin L.D., and Compagnone N.A. Biosynthesis and action of neurosteroids. Brain Res Rev 37 (2001) 3-12
88. Meyer J.H., Lee S., Wittenberg G.F., Randall R.D., and Gruol D.L. Neurosteroid regulation of inhibitory synaptic transmission in the rat hippocampus in vitro. Neuroscience 90 (1999) 1177-1183
89. Michael A., Jenaway A., Paykel E.S., and Herbert J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry 48 (2000) 989-995
90. Migues P.V., Johnston A.N.B., and Rose S.P.R. Dehydroepiandosterone and its sulphate enhance memory retention in day-old chicks. Neuroscience 109 (2002) 243-251
91. A receptor diversity and pharmacology. Cell Tissue Res 326 (2006) 505-516
92. Molinari C., Battaglia A., Grossini E., Mary D.A.S.G., Vassanelli C., and Vacca G. The effect of dehydroepiandrosterone on coronary blood flow in prepubertal anaesthetized pigs. J Physiol 549 (2003) 937-944
93. Molinari C., Battaglia A., Grossini E., Mary D.A.S.G., Vassanelli C., and Vacca G. The effect of dehydroepiandrosterone on regional flow in prepubertal anaesthetized pigs. J Physiol 557 (2004) 307-319
94. Monnet F.P. Functional cooperation between neurosteroids and D2 dopamine antagonists on KCl-evoked [3H]noradrenaline release: modulation by calcium channel blockers. J Neuroendocrinol 14 (2002) 955-962
95. Murray H.E., and Gillies G.E. Differential effects of neuroactive steroids on somatostatin and dopamine secretion from primary hypothalamic cell cultures. J Neuroendocrinol 9 (1997) 287-295
96. Nguyen T., Porter J., and Svec F. Dehydroepiandrosterone (DHEA) decreases open-field spontaneous activity of Zucker rats. Physiol Behav 67 (1999) 725-731
97. Nicolas L.B., Pinoteau W., Papot S., Routier S., Guillaumet G., and Mortaud S. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Res 922 (2001) 216-222
98. Nunes-de-Souza V., Nunes-de-Souza R.L., Rodgers R.J., and Canto-de-Souza A. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behavior in mice. Behav Brain Res 187 (2008) 72-79
99. Oades R.D., and Schepker R. Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinology 19 (1994) 373-385
100. A function through distinct sites. Brain Res 830 (1999) 72-87
101. Pham J., Porter J., Svec D., Eiswirth C., and Svec F. The effect of dehydroepiandrosterone on Zucker rats selected for fat food preference. Physiol Behav 70 (2000) 431-441
102. Porter J., Van Vrancken M., Corll C., Thompson H., and Svec F. The influence of dehydroepiandrosterone and 8-OH-DPAT on the caloric intake and hypothalamic neurotransmitters of lean and obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288 (2005) R928-R935
103. Prast P., and Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol 64 (2001) 51-68
104. Rabkin J.G., McElhiney M.C., Rabkin R., McGrath P.J., and Ferrando S.J. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am J Psychiatry 163 (2006) 59-66
105. Ramirez J., Garnica R., Boll M.C., Montes S., and Rios C. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study. Schizophr Res 68 (2004) 357-361
106. Reddy D.S., and Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res 799 (1998) 215-229
107. Reddy D.S., and Kulkarni S.K. Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice. Eur J Pharmacol 345 (1998) 55-59
108. 5-derivatives in the rodent brain. Neurochem Int 7 (1985) 953-958
109. Robichaud M., and Debonnel G. Oestrogen and testosterone modulate the firing activity of dorsal raphe nucleus serotonergic neurones in both male and female rats. J Neuroendocrinol 17 (2005) 179-185
110. Romieu P., Martin-Fardon R., Bowen W.D., and Maurice T. σ1 Receptor-related neuroactive steroids modulate cocaine-induced reward. J Neurosci 23 (2003) 3572-3576
111. Schmidt P.J., Daly R.C., Bloch M., Smith M.J., Danaceau M.A., Simpson St.Clair L., et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62 (2005) 154-162
112. Semeniuk T., Jhangri G.S., and Le Mellédo G.M. Neuroactive steroid levels in patients with generalized anxiety disorder. J Neuropsychiatry Clin Neurosci 13 (2001) 396-398
113. A receptors. Neuropharmacology 38 (1999) 267-271
114. Shibuya K., Takata N., Hojo Y., Furukawa A., Yasumatsu N., Kimoto T., et al. Hippocampal cytochrome P450s synthesize brain neurosteroids which are paracrine neuromodulators of synaptic signal transduction. Biochim Biophys Acta 1619 (2003) 301-316
115. Shin C.Y., Choi J.W., Jang E.S., Ju C., Kim W.K., Kim H.C., et al. Dehydroepiandrosterone inhibits the death of immunostimulated rat C6 glioma cells deprived of glucose. Brain Res 922 (2001) 267-275
116. Silver H., Knoll G., Isakov V., Goodman C., and Finkelstein Y. Blood DHEAS concentrations correlate with cognitive function in chronic schizophrenia patients. A pilot study. J Psychiatr Res 39 (2005) 569-575
117. Simoncini T., Mannella P., Fornari L., Varone G., Caruso A., and Genazzani A.R. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 144 (2003) 3449-3455
118. Singh V., Kalimi M., Phan T.H., and Broadle-Biber M.C. Intracranial dehydroepiandrosterone blocks the activation of tryptophan hydroxylase in resposne to acute sound stress. Mol Cell Neurosci 5 (1994) 176-181
119. Sobczak S., Honig A., van Duinen M.A., and Riedel W.J. Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. Bipolar Disord 4 (2002) 347-356
120. A receptor complex reveals that it may act via the picrotoxin site. J Pharmacol Exp Ther 282 (1997) 827-833
121. Strömstedt M., and Waterman M.R. Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain. Mol Brain Res 34 (1995) 75-88
122. Strous R.D., Maayan R., Lapidus R., Stryjer R., Lustig M., Kotler M., et al. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 60 (2003) 133-141
123. Strous R.D., Maayan R., Lapidus R., Goredetsky L., Zeldich E., Kotler M., et al. Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology. Schizophr Res 71 (2004) 427-434
124. Suárez C., Vela J., García-Tornadú I., and Becu-Villalobos D. Dehydroepiandrosterone (DHEA) modulates GHRH, somatostatin and angiotensin II action at the pituitary level. J Endocrinol 185 (2005) 165-172
125. Sullivan S.D., and Moenter S.M. Neurosteroids alter γ-aminobutyric acid postsynaptic currents in Gonadotropin-releasing hormone neurons: a possible mechanism for direct steroidal control. Endocrinology 144 (2003) 4366-4375
126. Suzuki E., Nakaki T., Nakamura M., and Miyaoka H. Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia. J Psychiatry Neurosci 28 (2003) 288-292
127. Tomas-Camardiel M., Sanchez-Hidalgo M.C., Sanchez del Pino M.J., Navarro A., Machado A., and Cano J. Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17β-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum. Neuroscience 109 (2002) 569-584
128. Trabace L., and Kendrick K.M. Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J Neurochem 75 (2000) 1664-1674
129. Uchida H., Mizuno K., Yoshida A., and Ueda H. Neurosteroid-induced hyperalgesia through a histamine release is inhibited by progesterone and p,p′-DDE, an endocrine disrupting chemical. Neurochem Int 42 (2003) 401-407
130. Vacheron-Trystam M.N., Cheref S., Gauillard J., and Plas J. À propous d'un cas de manie sous DHEA. L'Encephale 28 (2002) 563-566
131. 3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study. J Pharmacol Exp Ther 275 (1995) 358-367
132. Weizman R., Paz L., Peter Y., Toren P., and Pick C.G. Behavioral effects of agents active at the γ-aminobutyric acid receptor complex in the staircase paradigm. Brain Res 901 (2001) 137-142
133. Wen S., Dong K., Onolfo J.P., and Vincens M. Treatment with dehydroepiandrosterone sulfate increases NMDA receptors in hippocampus and cortex. Eur J Pharmacol 430 (2001) 373-374
134. West A.R., and Grace A.A. Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo. J Neurophysiol 83 (2000) 1796-1808
135. Williams M.R.I., Dawood T., Ling S., Dai A., Lew R., Myles K., et al. Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab 89 (2004) 4708-4715
136. Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156 (1999) 646-649
137. Xilouri M., and Papazafiri P. Anti-apoptotic effects of allopregnanolone on P19 neurons. Eur J Neurosci 23 (2006) 43-54
138. Xing G., Chavko M., Zhang L.X., Yang S., and Post R.M. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr Res 58 (2002) 21-30
139. Zwain I.H., and Yen S.S.C. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140 (1999) 3843-3852
140. Zwain I.H., and Yen S.S.C. Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 140 (1999) 880-887
141. 2+-ATPase activity in rat cortical and cerebellar synaptosomal membranes. Biochem Biophys Res Commun 212 (1995) 178-183
142. 2+-ATPase activity. Biochim Biophys Acta 1437 (1999) 257-264